Technetium (^99mTc) mertiatide

Technetium (^99mTc) mertiatide
Clinical data
Trade names	Technescan Mag3
License data	US DailyMed: Tc 99m mertiatide;
Routes of; administration	Intravenous
ATC code	V09CA03 (WHO) ;
Legal status
Legal status	US: ℞-only;
Identifiers
CAS Number	125224-05-7;
PubChem CID	11441509;
ChemSpider	32702040;
UNII	36ITO9SKQJ;
KEGG	D06039;
Chemical and physical data
3D model (JSmol)	Interactive image;
	SMILES C(C(=NCC(=O)[O-])[O-])N=C(CN=C(C[S-])[O-])[O-].O=[99Tc+3].[Na+].[Na+];
	InChI InChI=1S/C8H13N3O5S.2Na.O.Tc/c12-5(2-10-7(14)4-17)9-1-6(13)11-3-8(15)16;;;;/h17H,1-4H2,(H,9,12)(H,10,14)(H,11,13)(H,15,16);;;;/q;2*+1;;+3/p-5/i;;;;1+1; Key:JVYYEQVAPXSUSY-RCUQKECRSA-I;

Technetium (^99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys.^[1] It is a renal imaging agent that is given by intravenous injection.^[1]

It was approved for medical use in the United States in June 1990.^[2]

Medical uses

Technetium (^99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.^[1]

Chemistry

The active ingredient, betiatide, is reconstituted with sodium pertechnetate ^99mTc injection to form technetium (^99mTc) mertiatide.^[1]

References

^ ^a ^b ^c ^d ^e "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December 2022. Archived from the original on 2 February 2023. Retrieved 1 February 2023.
^ "Technescan Mag3: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 13 December 2022. Retrieved 1 February 2023.

[Technescan_Mag3_FDA_label-1] "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December 2022. Archived from the original on 2 February 2023. Retrieved 1 February 2023.

[2] "Technescan Mag3: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 13 December 2022. Retrieved 1 February 2023.

[1]

[2]